Follow
Mark Dornan
Mark Dornan
Dana-Farber Cancer Institute / Harvard Medical School
Verified email at dfci.harvard.edu
Title
Cited by
Cited by
Year
Trapping biosynthetic acyl-enzyme intermediates with encoded 2, 3-diaminopropionic acid
N Huguenin-Dezot, DA Alonzo, GW Heberlig, M Mahesh, DP Nguyen, ...
Nature 565 (7737), 112-117, 2019
962019
Gene PA2449 is essential for glycine metabolism and pyocyanin biosynthesis in Pseudomonas aeruginosa PAO1
BR Lundgren, W Thornton, MH Dornan, LR Villegas-Peñaranda, ...
Journal of bacteriology 195 (9), 2087-2100, 2013
602013
First-in-class small molecule potentiators of cancer virotherapy
MH Dornan, R Krishnan, AM Macklin, M Selman, N El Sayes, HH Son, ...
Scientific reports 6 (1), 26786, 2016
402016
Impact of Detergents on Membrane Protein Complex Isolation
YC Lee, JA Bååth, RM Bastle, S Bhattacharjee, MJ Cantoria, ...
Journal of proteome research 17 (1), 348-358, 2018
332018
Simplified and robust one‐step radiosynthesis of [18F]DCFPyL via direct radiofluorination and cartridge‐based purification
MH Dornan, JM Simard, A Leblond, D Juneau, G Delouya, F Saad, ...
Journal of Labelled Compounds and Radiopharmaceuticals 61 (10), 757-763, 2018
162018
Armeniaspirols inhibit the AAA+ proteases ClpXP and ClpYQ leading to cell division arrest in Gram-positive bacteria
P Labana, MH Dornan, M Lafrenière, TL Czarny, ED Brown, JP Pezacki, ...
Cell Chemical Biology 28 (12), 1703-1715. e11, 2021
102021
Hexanes/acetonitrile: a binary solvent system for the efficient monosilylation of symmetric primary and secondary diols
BI Wilke, MH Dornan, J Yeung, CN Boddy, A Pinto
Tetrahedron letters 55 (16), 2600-2602, 2014
102014
Pre-clinical characterization of the novel FAP targeting ligand PNT6555 for the imaging and therapy of cancer
R Hallett, S Poplawski, K Novakowski, M Dornan, SH Ahn, S Pan, W Wu, ...
Journal of Nuclear Medicine 63 (supplement 2), 4028-4028, 2022
62022
A high molar activity 18F-labeled TAK-875 derivative for PET imaging of pancreatic β-cells
MH Dornan, D Petrenyov, JM Simard, A Aliaga, G Xiong, J Ghislain, ...
EJNMMI Radiopharmacy and Chemistry 3, 1-15, 2018
42018
Armeniaspirol analogues with more potent Gram-positive antibiotic activity show enhanced inhibition of the ATP-dependent proteases ClpXP and ClpYQ
MG Darnowski, TD Lanosky, P Labana, JT Brazeau-Henrie, ND Calvert, ...
RSC Medicinal Chemistry 13 (4), 436-444, 2022
32022
Synthesis of a 11C-Isotopologue of the B-Raf-Selective Inhibitor Encorafenib Using In-Loop [11C]CO2 Fixation
MH Dornan, D Petrenyov, JM Simard, M Boudjemeline, R Mititelu, ...
ACS omega 5 (33), 20960-20966, 2020
32020
Compositions and methods for viral sensitization
JS Diallo, CN Boddy, M Dornan, R Krishnan, R Arulanandam, F Le Boeuf, ...
US Patent 10,654,839, 2020
32020
Radiosynthesis of the 11C‐methyl derivative of LBQ657 for PET investigation of the neprilysin inhibitor sacubitril
VR Teyssier, JM Simard, MH Dornan, F Tournoux, JN DaSilva
Journal of Labelled Compounds and Radiopharmaceuticals 63 (2), 65-71, 2020
22020
Preclinical Development of PNT6555, a Boronic Acid–Based, Fibroblast Activation Protein-α (FAP)–Targeted Radiotheranostic for Imaging and Treatment of FAP-Positive Tumors
SE Poplawski, RM Hallett, MH Dornan, KE Novakowski, S Pan, ...
Journal of Nuclear Medicine 65 (1), 100-108, 2024
12024
Development and characterization of a next-generation Ac-225-PSMA radioligand
A Vito, M Dornan, T Beale, A Felten, M Ernste, Q Nguyen, S Ahn, ...
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022
12022
Compositions and methods for enhancing oncolytic virus efficacy
JS Diallo, CN Boddy, M Dornan, R Krishnan, F Le Boeuf, JC Bell, ...
US Patent App. 15/542,480, 2018
12018
Compositions and methods for viral sensitization
JS Diallo, CN BODDY, M DORNAN, R KRISHNAN, R ARULANANDAM, ...
12016
Method development for centralized clinical production of 177Lu-PNT2002
M Dornan, L Southcott, SH Ahn, A Belanger, V Hergott, J McCann
Nuclear Medicine and Biology 126, 108540, 2023
2023
Preclinical application of novel isotopes and combination therapy with the FAP targeting ligand PNT6555
K Novakowski, SH Ahn, M Dornan, A Belanger, S Poplawski, ...
Journal of Nuclear Medicine 64 (supplement 1), P180-P180, 2023
2023
Compositions and methods for viral sensitization
JS Diallo, CN Boddy, M Dornan, R Krishnan, R Arulanandam, F Le Boeuf, ...
US Patent App. 17/710,386, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20